Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery-Reference-Cited by-同舟云学术

Procalcitonin and Other Common Biomarkers Do Not Reliably Identify Patients at Risk for Bacterial Infection After Congenital Heart Surgery

Published:2019-03 Issue:3 Volume:20 Page:243-251
ISSN:1529-7535
Container-title:Pediatric Critical Care Medicine
language:en
Short-container-title:Pediatric Critical Care Medicine

Author:

D’Souza Shane,Guhadasan Rathi,Jennings Rebecca,Siner Sarah,Paulus Stéphane,Thorburn Kent,Chesters Christine,Downey Colin,Baines Paul,Lane Steven,Carrol Enitan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. State Sepsis Mandates — A New Era for Regulation of Hospital Quality

2. Sepsis in children

3. Nosocomial Infections in Pediatric Cardiac Surgery, Italy

4. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target

5. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative Serum Procalcitonin Level Can Be a Useful Marker of Bacterial Infection after Cardiac Surgery Utilizing Cardiopulmonary Bypass;Journal of Cardiac Surgery;2024-04-13

2. Fatores de Risco para Infecção da Ferida Operatória em Pacientes Submetidos à Cirurgia Cardíaca Pediátrica;Arquivos Brasileiros de Cardiologia;2023-12

3. Fatores de Risco para Infecção do Sítio Cirúrgico Pós Cirurgia Cardíaca Pediátrica;Arquivos Brasileiros de Cardiologia;2023

4. Implementation of a 24-hour infection diagnosis protocol in the pediatric cardiac intensive care unit (CICU);Infection Control & Hospital Epidemiology;2022-11-16

5. Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial;BMJ Open;2022-01